Skip to main content

Table 4 Quantitative values of different hepatic marker viz. DNA, RNA, protein, and AFP levelsa, * after the 21st week of exposure of harmalol and carcinogens

From: Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma

Groups

DNA

RNA

Normal serum protein

AFP level in serum

I

0.7 ± 0.1

0.9 ± 0.08

13.5 ± 0.1

0.30 ± 0.02

II

0.75 ± 0.2

0.92 ± 0.009

12.9 ± 0.2

0.34 ± 0.03

III

2.1 ± 0.6

2.6 ± 0.4

8.4 ± 0.5

0.80 ± 0.05

IV

1.9 ± 0.4

2.2 ± 0.3

9.2 ± 0.5

0.79 ± 0.04

V

2.6 ± 0.7

2.8 ± 0.6

7.6 ± 0.8

0.83 ± 0.07

VI

1.6 ± 0.4

1.8 ± 0.2

10.2 ± 0.3

0.55 ± 0.03

VII

1.2 ± 0.3

1.6 ± 0.1

11.8 ± 0.2

0.42 ± 0.02

  1. aValues represented means ± SD
  2. *Significantly different from the control groups (p < 0.05)